Interview: Anna Maria Porrini – President, Boehringer Ingelheim Italy
Dr. Anna Maria Porrini, President of Boehringer Ingelheim Italy shares her vision for the company, how she intends…
Boehringer Ingelheim Italy
Last updated: 11.12.2015
Boehringer Ingelheim Italy conducts its activities in Milan and Fornovo San Giovanni.The Research is conducted in the modern chemical Birit (Boehringer Ingelheim Research Italy), located in Milan, and working in close relation with that of Biberach, in southern Germany. Chemical production is performed by Bidachem SpA in Fornovo San Giovanni which manufactures active pharmaceutical ingredients. The commercial sector is structured in three divisions: Division of Hospital and Prescription Medicines , the Wellbeing and Self-Medication division, and the Veterinary Division.
Contact
Address: Via Lorenzini n.8 – 20139 Milano, Italy
Tel: +39 0253551
Web: http://www.boehringer-ingelheim.it/
Interviews
Interview with Sergio Daniotti, Country Manager, Boehringer Ingelheim Italy
The main distinctive point of Boehringer Ingelheim Italy within the group is its business structure, which relies…
Related
Italy / Mandatory COVID-19 Vaccines for Healthcare Workers; Chiesi & Angelini’s AI Investments; Sputnik V Manufacturing
The latest from Italian pharma, including the government’s decision to make COVID-19 vaccines mandatory for all…
Italy / Stevanato’s $5 bn valuation; Zolgensma Approval; Sputnik V Manufacturing
The latest from Italian pharma, including the foreign minister’s plea for delivering on COVID-19 vaccine…
Italy / Menarini CEO on Averting Future Health Crises; Alfasigma Hackathon; January COVID Vaccines
A roundup of some of the most important recent stories from Italian pharma, including an in-depth interview with…
Pricing / Italy Takes Global Transparency Lead by Forcing Pharma to Disclose Public R&D Funding
In July 2020, Italy became the first country in the world to mandate pharma companies to disclose data surrounding…
News Roundup / Italy Pharma July 2020
Below we present recent news from Italy’s biopharma industry, including the recent acquisition of Stemline…
M&A / Menarini Makes Big US Oncology Move with Stemline Acquisition
Menarini Group, the largest Italian pharmaceutical company by turnover, has made its first move into the US…
Internationalization / Chiesi Moves into Rare Diseases & the US Market
Italian mid-cap firm Chiesi is continuing its expansion in the USA market with the launch of a Boston-based…
Interview: Luca G. Guidotti – Deputy Scientific Director, San Raffaele…
Prof. Luca G. Guidotti discusses the esteemed positioning of San Raffaele within the global scientific community,…
Interview: Gianvito Martino – Scientific Director & Director of the…
The division of neuroscience at the San Raffaele Scientific Institute is one of the best worldwide performers in…
Interview: Angelo Corti – Director, Division of Experimental Oncology, San…
Professor Angelo Corti, Director of the Experimental Oncology division of the SRSI, discusses approaches to…
Interview: Paola Pozzi – Head, Office of Biotechnology Transfer, San…
Dr. Paola Pozzi, the head of the Office of Biotechnology Transfer at the San Raffaele Scientific Institute,…
Italian Pharma SMEs: Family Knows Best!
Italy’s traditional family-owned pharmaceutical companies are one of its greatest strengths; but these companies…
